Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Atazanavir in treatment-experienced patients.
Two industry-sponsored prospective studies provide some clarification regarding the optimal use of the new PI atazanavir in PI-experienced patients.